Vanguard Global Advisers »

Abeona Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $83k 19k 4.48

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Abeona Therapeutics

Nantahala Capital Management
BlackRock
AIGH Capital Management
Cable Car Capital
Vanguard Group
Suvretta Capital Management
Vanguard Capital Management
Propel Bio Management
Kennedy Capital Management
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Nan Fung Trinity
Stonepine Capital Management
State Street Corporation

View all funds holding Abeona Therapeutics